期刊文献+

甲氨喋呤血药浓度监测在髓外白血病防治中的应用 被引量:1

Study of the blood concentration of M TX in the treatment of children leukemia out of spinal
下载PDF
导出
摘要 目的探讨大剂量甲氨喋呤在小儿髓外白血病防治中的药代动力学改变及血药浓度监测的临床意义。方法52例急性淋巴细胞性白血病患儿,为预防髓外白血病应用大剂量甲氨喋呤3.0g/m2,治疗3个疗程,每疗程进行3次血药浓度监测。结果用药后24小时血药浓度出现峰值,48小时回复到用药时水平。结论根据测定的甲氨喋呤血药浓度水平结合临床,可适当缩短给药间期或增加药物剂量。 Objective To investigate the pharmacokinetic s and pharmacodynamics of high dose o f MTX in the treatment of children leukemia out of spinal.Methods Fifty-two children received 3.0g /m 2 MTX for three times in each course of t reat-ment and the blood concentration of M TX was monitored.Results The peaks of blood concentration of M TX appeared at 24th after administration and returned t o the beginning level at 48th.Conclusion The study indicates that proper shortening of in-tervals between administration or i ncreasing the dosage may provide more effective treatment for children l eukemia.
出处 《中国航天医药杂志》 2002年第6期12-14,共3页 Medical Journal of CASE
关键词 甲氨喋呤 血药浓度 监测 髓外白血病 防治 Methotrexate Leukemia Blood concen tration
  • 相关文献

参考文献8

  • 1[1]Treon SP, Chabner BA. Concepts in use of high-dose methotrexate therapy. Clin Chem,1996, 42(8 Pt 2): 1322-1329
  • 2郝良纯,张立忠,郭静坤.大剂量氨甲喋呤对急性淋巴细胞白血病患儿各脏器功能的影响[J].中华儿科杂志,1998,36(1):8-11. 被引量:17
  • 3马金兰,汤致强.大剂量甲氨喋呤的药代动力学[J].中国新药杂志,1994,3(2):49-51. 被引量:8
  • 4[4]Relling MV, Fairclough D, Ayers D, et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol, 1994,12(8): 1667-1672
  • 5[5]Hum MC, Smith AK, Lark RH, et al. Evidence for negative feed-back of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro. Pharmacotherapy, 1997, 17(6): 1260-1266
  • 6[6]Najjar TA, Fawaz IM. Pharmacokinetics of methotrexate in children with acute lymphocytic leukemia. Chemotherapy, 1993, 39(4): 242-247
  • 7[7]Hashimoto H, Kubota M, Shimizu T, et al. Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute 1eukemia or non-Hodgkin lymphoma in childhood. Leukemia, 1992, 6(11): 1199-1202
  • 8[8]Odoul F, Le Guejlec C, Lamagnere, JP, et al. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach. Fundam Clin Pharmacol, 1999,13(5): 595-604

二级参考文献4

  • 1郭子宽,综合临床医学,1995年,11期,266页
  • 2张素芬,中华内科杂志,1994年,33卷,99页
  • 3孙桂香,中华儿科杂志,1993年,31卷,285页
  • 4刘继智,重庆医药,1991年,20卷,119页

共引文献22

同被引文献5

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部